A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS). - Université de Bretagne Occidentale Access content directly
Conference Papers Year : 2019

A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).

Nieves Diaz
  • Function : Author
Andrew Payne
  • Function : Author
Eric Helmer
  • Function : Author
Dionne Cain
  • Function : Author
Benjamin Fisher
Xavier Mariette
  • Function : Author
  • PersonId : 861676
Francesca Barone

Domains

Immunology
No file

Dates and versions

hal-02150798 , version 1 (07-06-2019)

Identifiers

  • HAL Id : hal-02150798 , version 1

Cite

Maria Juárez, Nieves Diaz, Geoffrey I Johnston, Saba Nayar, Andrew Payne, et al.. A phase II randomised, double-blind, placebo-controlled, proof of concept study of oral seletalisib in patients with primary Sjögren’s syndrome (PSS).. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02150798⟩
36 View
0 Download

Share

Gmail Facebook X LinkedIn More